Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patients.

A. Contis, N. Gensous, J.F. Viallard, C. Goizet, C. Léauté-Labrèze, P. Duffau
Clin Otolaryngol. 2017-01-20; 42(4): 911-917
DOI: 10.1111/coa.12821


Read on PubMed

---

1. Clin Otolaryngol. 2017 Aug;42(4):911-917. doi: 10.1111/coa.12821. Epub 2017 Jan
20.

Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic
telangiectasia: retrospective, then prospective study, in a total of 21 patients.

Contis A(1), Gensous N(1), Viallard JF(2), Goizet C(3), Léauté-Labrèze C(4),
Duffau P(1).

Author information:
(1)Service de médecine interne et immunologie clinique, Hôpital Saint André,
Bordeaux, France.
(2)Service de médecine interne, Hôpital Haut- Lévêque, Pessac, France.
(3)Service de génétique médicale, Hôpital Pellegrin, Bordeaux, France.
(4)Service de dermatologie pédiatrique et Centre de référence maladies rares de
la peau, Hôpital Pellegrin, Bordeaux, France.

DOI: 10.1111/coa.12821
PMID: 28032956 [Indexed for MEDLINE]

Know more about